Document Detail

Overview of randomized clinical trials in acute heart failure syndromes.
MedLine Citation:
PMID:  16181824     Owner:  NLM     Status:  MEDLINE    
Acute heart failure syndromes (AHFS) are among the most frequent causes of hospitalizations in the United States and Europe. Despite current therapies, patients with AHFS have high readmission and mortality rates. The randomized, controlled clinical trial is the standard by which contemporary therapies are evaluated, yet this tool of clinical science only recently has been rigorously applied to the development of novel therapies for patients with AHFS. This review briefly discusses some of the challenges presented in designing a clinical trial of therapies for AHFS and to describe some of the recent trials with respect to these issues in established drugs (such as milrinone, dobutamine, nitroglycerin, nitroprusside, and nesiritide) that have been approved by the US Food and Drug Administration (FDA). Recent trials of current investigational agents, such as levosimendan (the Randomized Multicenter Evaluation of Intravenous Levosimendan Efficacy Versus Placebo in the Short-Term Treatment of Decompensated Heart Failure [REVIVE], the Calcium Sensitizer or Inotrope or None in Low-Output Heart Failure [CASINO] study, and the Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support [SURVIVE] trial), tezosentan (the Randomized Intravenous Tezosentan [RITZ] study and the Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies [VERITAS]), and tolvaptan (the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure [ACTIV-CHF] study), are also discussed.
John R Teerlink
Related Documents :
18036544 - The right heart and its distinct mechanisms of development, function, and failure.
2073654 - Is heart failure an abnormality of myocardial cell growth?
22076514 - Carvedilol: a countermeasure to heart failure.
11552224 - Anthracycline-induced cardiomyopathy.
9470344 - Can florida become the first state in the united states to take heart disease out of fi...
3993804 - Myocardial adenine pool depletion and recovery of mechanical function following ischemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  96     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-09-26     Completed Date:  2005-10-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  59G-67G     Citation Subset:  AIM; IM    
Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, California 94121-1545, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Cardiotonic Agents / therapeutic use*
Heart Failure / drug therapy*,  pathology
Randomized Controlled Trials as Topic
Vasodilator Agents / therapeutic use*
Reg. No./Substance:
0/Cardiotonic Agents; 0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndrom...
Next Document:  Pharmacology of new agents for acute heart failure syndromes.